ArticleNeurosurgical focus2021

Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing IL-12, in pet dogs with sporadic gliomas.

Nidal B Omar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.